Similar Papers

Paper Title
Journal
Date
Author
Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: Can we do better? Analysis of results obtained during the past two decades in 1669 French subjects
S Béliard ... E Bruckert
Atherosclerosis | VOL. 234
S Béliard, et. al.S Béliard ... E Bruckert
03 Mar 2014
ETESIAN: A phase 2B study of the efficacy, safety and tolerability of AZD8233, a PCSK9-targeted antisense oligonucleotide, in patients with dyslipidemia
A Hofherr ... B.C.L Carlsson
Atherosclerosis | VOL. 355
A Hofherr, et. al.A Hofherr ... B.C.L Carlsson
01 Aug 2022
Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants
Shunsuke Araki ... Koichi Kusuhara
Early Human Development | VOL. 90
Shunsuke Araki, et. al.Shunsuke Araki ... Koichi Kusuhara
15 Aug 2014
Prevalence, clinical characteristics and prognosis of intracranial artery atherosclerosis in heterozygous familial hypercholesterolemia: insights from magnetic resonance angiography imaging analysis
S Funabashi ... K Matsuki
European Heart Journal | VOL. 41
S Funabashi, et. al.S Funabashi ... K Matsuki
01 Nov 2020
View more papers

More From: European Heart Journal - Cardiovascular Pharmacotherapy

Paper Title
Journal
Date
Author
Risk of bleeding with the concurrent use of amiodarone and DOACs: A systematic review and meta-analysis
Faith Michael ... Mohammed Shurrab
European Heart Journal - Cardiovascular Pharmacotherapy | VOL. -
Faith Michael, et. al.Faith Michael ... Mohammed Shurrab
24 Dec 2024
The Untapped Potential of Guideline-Directed Heart Failure Pharmacotherapy: Consequences of Missed Opportunities
Ester J Herrmann ... Samuel Sossalla
European Heart Journal - Cardiovascular Pharmacotherapy | VOL. -
Ester J Herrmann, et. al.Ester J Herrmann ... Samuel Sossalla
24 Dec 2024
Management of dyslipidaemia in patients with comorbidities – facing the challenge Value and limitations of lipid lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver
Lisa Frühwald ... Heinz Drexel
European Heart Journal - Cardiovascular Pharmacotherapy | VOL. -
Lisa Frühwald, et. al.Lisa Frühwald ... Heinz Drexel
24 Dec 2024
Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction.
Bahira Shahim ... Juliane Jurga
European Heart Journal - Cardiovascular Pharmacotherapy | VOL. 10
Bahira Shahim, et. al.Bahira Shahim ... Juliane Jurga
15 Jan 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.